Influenza Vaccine
Biotech company receives flu vaccine production license from Chinese state FDA
Published in Hepatitis Weekly, August 29th, 2005
The SFDA issued a new drug certificate for Anflu in March, 2005, which provided Sinovac proprietary privileges for the vaccine. The production license was received July 27 (Beijing time), and authorizes Sinovac to begin vaccine production.
Sinovac has already installed and tested the production equipment in the facility and is ready to complete the final step in the application process for Good Manufacturing Practices (GMP) certification. Once approved, Sinovac will have 3 GMP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-08-29)
More Articles from Hepatitis Weekly
- Chronic Hepatitis B
Virus and transaminase levels foreshadow the emergence of hepatitis B mutants - Chronic Hepatitis C
Ondansetron relieves fatigue in patients infected with hepatitis C - Chronic Liver Disease
Albumin dialysis relieves portal pressure in patients with alcoholic hepatitis - Drug Delivery
Engineered bio-nanocapsules transport proteins to liver cells - Hepatitis C Therapy
Ribavirin priming makes chronic hepatitis C combination therapy more effective - Alcoholism
Glasgow scores predict patients at risk for alcoholic hepatitis-related death - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
